Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Invitae Comprehensive Myopathy Panel Invitae United States | 143 | 70 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Invitae United States | 353 | 208 |
|
PreventionGenetics, part of Exact Sciences United States | 21 | 21 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 4 | 1 |
|
Amyotrophic lateral sclerosis panel. 32-gene NGS panel. Genologica Medica Spain | 66 | 32 |
|
Frontotemporal dementia and/or Amyotrophic Lateral Sclerosis: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 30 | 30 |
|
Amyotrophic Lateral Sclerosis (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 25 | 30 |
|
Congenital Myopathy and Distal Myopathy NGS panel Asper Biogene Asper Biogene LLC Estonia | 78 | 41 |
|
AMYOTROPHIC LATERAL SCLEROSIS (ALS) (AUTOSOMAL DOMINANT) Laboratorio de Genetica Clinica SL Spain | 14 | 17 |
|
Asper Biogene Asper Biogene LLC Estonia | 22 | 22 |
|
Invitae Amyotrophic Lateral Sclerosis Panel Invitae United States | 29 | 21 |
|
Nonprevalent Amyotrophic Lateral Sclerosis Advanced Sequencing Evaluation Athena Diagnostics United States | 24 | 15 |
|
Amyotrophic Lateral Sclerosis Advanced Evaluation Athena Diagnostics United States | 19 | 17 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 42 | 54 |
|
Asper Biogene Asper Biogene LLC Estonia | 180 | 139 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.